Subject Content 검색 11 NEXTBIOMEDICAL, Fast Resorbable Microsphere ‘Nexsphere-F™’ : Clinical Study Results on 155 Patients Published in the JVIR 2025-03-17 10 Interventional News has been issued mentioning Nexsphere-F™ 2025-03-11 9 NEXTBIOMEDICAL Secures FDA Breakthrough Device Designation for Innovative Resorbable Microsphere 'Nexsphere-F™' 2025-03-06 8 Nexpowder™ received PMDA approval 2025-02-20 7 NEXTBIOMEDICAL Applies for FDA Breakthrough Device Designation for ‘Nexsphere-F™’. 2025-02-10 6 Nextbiomedical to Exhibit at GEST MSK 2025 2025-01-24 5 NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Os... 2025-01-15 4 Nexpowder is US FDA Cleared(LGIB) 2024-11-28 3 Award-winning MSK embolization research shows ‘higher safety profile and broader indication’ 2023-10-04 2 Canada Health Approval for Nexpowder 2022-11-16 1 2
11 NEXTBIOMEDICAL, Fast Resorbable Microsphere ‘Nexsphere-F™’ : Clinical Study Results on 155 Patients Published in the JVIR 2025-03-17 10 Interventional News has been issued mentioning Nexsphere-F™ 2025-03-11 9 NEXTBIOMEDICAL Secures FDA Breakthrough Device Designation for Innovative Resorbable Microsphere 'Nexsphere-F™' 2025-03-06 8 Nexpowder™ received PMDA approval 2025-02-20 7 NEXTBIOMEDICAL Applies for FDA Breakthrough Device Designation for ‘Nexsphere-F™’. 2025-02-10 6 Nextbiomedical to Exhibit at GEST MSK 2025 2025-01-24 5 NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Os... 2025-01-15 4 Nexpowder is US FDA Cleared(LGIB) 2024-11-28 3 Award-winning MSK embolization research shows ‘higher safety profile and broader indication’ 2023-10-04 2 Canada Health Approval for Nexpowder 2022-11-16 1 2
